Annual Drug Patent Expirations for LYVISPAH
Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug.
This drug has nine patent family members in eight countries.
The generic ingredient in LYVISPAH is baclofen. Two suppliers are listed for this compound. Additional details are available on the baclofen profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com